Unlock intelligence hidden in real-world evidence, licensing deal structures, and proprietary partnership data. Connect private signals to commercial strategy with the precision your BD and HEOR teams demand.
A panel with interactive visualisations — no login required. Click and explore.
Public data tells half the story. The other half — the decisive half — lives in private networks.
CrossIntell Private surfaces proprietary signals — from real-world patient data to structured deal intelligence — that public sources simply cannot provide.
Integrate real-world evidence streams — claims data, EHR signals, registry outcomes — into your market access and HTA strategy. Demonstrate comparative effectiveness with evidence that resonates with payers.
Track structured deal intelligence across in-licensing, out-licensing, co-promotion, and acquisition activity. Identify partnership opportunities before they become public — and model deal economics in advance.
Map the full ecosystem of potential partners — from CROs and data providers to regional distributors and payer advisory firms. Identify relationship gaps before they become execution bottlenecks.
Model the return on licensing deals, RWE investment, and partnership structures against market access scenarios. Translate complex deal terms into net present value across your portfolio horizon.
Bring proprietary intelligence into your commercial strategy. Early access reserved for qualified pharma and medtech organisations.
Request Early Access